Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,323,076
-$5,082,585 QoQ
Shares Held
221,058
-40.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#581
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $150,710,322 across 7 Drug Manufacturers - General names. PFE ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
311,108 | $39,977,378 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
294,685 | $37,230,502 | |
| 3 | LLY |
ELI LILLY & Co
|
27,350 | $32,804,413 | |
| 4 | ABBV |
AbbVie Inc.
|
118,057 | $29,707,863 | |
| 5 | PFE |
Pfizer Inc
This page
|
221,058 | $5,323,076 | |
| 6 | JNJ |
Johnson & Johnson
|
20,023 | $5,085,241 | |
| 7 | BIIB |
Biogen Inc.
|
2,693 | $581,849 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,323,076 | 221,058 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,405,661 | 370,572 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,359,943 | 416,062 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,387,460 | 564,657 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,833,498 | 611,943 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,307,539 | 209,453 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,032,360 | 265,072 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,626,587 | 263,531 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,155,381 | 255,732 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,544,837 | 235,850 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $11,233,253 | 390,179 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $12,095,307 | 364,646 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $8,201,207 | 223,588 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $6,431,997 | 157,647 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $7,372,411 | 143,880 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $9,430,280 | 215,500 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $10,770,642 | 205,429 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $6,543,831 | 126,402 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $10,722,476 | 181,583 | Shares | Sole | 2025-07-09 | |
| 2021-09-30 | $3,028,119 | 70,405 | Shares | Sole | 2025-07-09 | |
| 2021-06-30 | $2,126,153 | 54,294 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $4,661,496 | 128,664 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $3,259,525 | 88,550 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $3,470,605 | 94,567 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $3,128,412 | 95,670 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $2,985,185 | 91,458 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||